Drugs / Liposom Forte
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04975724 | Apr 2019 → Oct 2025 | major depressive disorder | Fidia Farmaceutici s.p.a. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liposom Forte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04975724 ↗ |
| Modality | Other / unclassified | “Liposom Forte 28mg/2ml solution for injection contains a mixture of purified hypothalamic phospholipids (PLs) from swine brains.” NCT04975724 ↗ |